November 26, 2024
Equity.Guru
Investment information for the new generation
Search
Search
Latest News
Digital Twinning, and how EdgeTI (CTRL.V) is a serious story you’ve never heard of
Bionxt Solutions (BNXT.C): Seeking to confirm national-level cancer drug patent
Why Prospera Energy (PEI.V) might be a transformational investment opportunity in Canadian oil & gas
Sparc AI (SPAI.C) completes development of drone advanced target acquisition system
Plurilock (PLUR.V) lands $19 million deal, largest in their history
Rex Resources (OWN.V) continues gearing up with BC gold property
Home
By Topic
Agriculture
Biotech
Cannabis
Entertainment
Finance
Health Science
Military
Resources
Technology
Transport
By Series
Chris’ Corner
Education
Market Moment
Sector Roundup
Today’s Idea
Podcasts
EG Interviews
Sportsbar Radio with Rob Fai
Jody Vance
Videos
5 Easy Questions
Chart Attack
Chris’ Corner
Daily Rant
Finance 101
Gauntlet with Chris Parry
Investor Roundtable
Jody Vance
Three Minute Hits
About
Who we are
Capital Markets Program
Disclaimer
Menu
Home
By Topic
Agriculture
Biotech
Cannabis
Entertainment
Finance
Health Science
Military
Resources
Technology
Transport
By Series
Chris’ Corner
Education
Market Moment
Sector Roundup
Today’s Idea
Podcasts
EG Interviews
Sportsbar Radio with Rob Fai
Jody Vance
Videos
5 Easy Questions
Chart Attack
Chris’ Corner
Daily Rant
Finance 101
Gauntlet with Chris Parry
Investor Roundtable
Jody Vance
Three Minute Hits
About
Who we are
Capital Markets Program
Disclaimer
Cybin: Researching Psychedelic Therapies for a Variety of Issues Using a Range of Delivery Methods
Reza Golzadeh
August 6, 2021
Related Posts
Cybin (CYBN.NE) gets final approval to list on NYSE American and announces public offering
Cybin files 13th provisional patent application focused on building up its telemedicine capabilities
VIDEO: Cybin (CYBN.NE) Completes 51st Pre-Clinical Psychedelic Molecule Study
VIDEO: Cybin (CYBN.NE) selects SAD and GAD as targets for their CYB004 psychedelic molecule
VIDEO: Cybin (CYBN.NE) files international patent application with Patent Cooperation Treaty (PCT)
VIDEO: Cybin (CYBN.NE) receives approval from IRB for CYB001 Phase II clinical trial
More on
CYBN.NE